Novel technique for DSAEK yields thin grafts

Article

A novel technique for performing Descemet stripping automated endothelial keratoplasty (DSAEK) consistently yields thin grafts, according to recently published research in the British Journal of Ophthalmology.

A novel technique for performing Descemet stripping automated endothelial keratoplasty (DSAEK) consistently yields thin grafts, according to recently published research in the British Journal of Ophthalmology.

The team, led by Professor Joaquim Neto Murta (Ophthalmology Unit, Centro Hospitalar e Universitário de Coimbra, Praceta Mota Pinto, Coimbra, Portugal), prepared 25 DSAEK grafts using a novel technique. The technique involved two sequential cuts, the first of which was of variable thickness using a femtosecond laser and the second was performed using a 300 µm microkeratome head.

To analyse the new technique the team measured spectacle corrected visual acuity and endothelial cell density (with specular microscopy and anterior segment optical coherence tomography) at the periphery and the centre of the grafts both preoperatively and at 1, 3 and 6 months postoperatively.

No irregular cuts or perforations occurred during tissue preparation and the team found that central graft thickness was 79.6 µm and 69.3 µm at 3 and 6 months respectively. Spectacle corrected distance visual acuity was found to improve from 0.91 logMAR preoperatively to 0.11 logMAR at 6 months post-op.

In conclusion, the novel technique was deemed to provide consistently thin grafts of lower than 100 µm and good visual acuity outcomes. Additionally, no graft detachments were encountered and so there was no wastage of donor tissue.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.